Management of Stage 3 T4N1 Lung Cancer with Unresolved Lung Abscess

Introduction to Treatment Approach

The British Journal of Cancer recommends that active infection, such as a lung abscess, must be treated and resolved before initiating definitive cancer therapy, as it represents a contraindication to both surgery and chemoradiation, with pneumonectomy following neoadjuvant treatment carrying significantly higher morbidity risk 1

The British Journal of Cancer suggests that T4N0 tumors can be treated by wide excision in carefully selected patients, but there is no consensus on pneumonectomy usefulness in N1 tumors 1, 2, 3
The American College of Surgeons and medical oncology societies recommend evaluating resectability through multidisciplinary consultation involving thoracic surgery, medical oncology, and radiation oncology 4
For potentially resectable T4N1 disease, the National Comprehensive Cancer Network recommends neoadjuvant chemotherapy with cisplatin plus at least one other drug 5, 4
The American Thoracic Society suggests assessing pulmonary function with VO2 max determination, with a surgical threshold of approximately 15 ml/kg/min 1, 4
Acceptable operative mortality should be <6% for pneumonectomy and <2% for lobectomy, as recommended by the Society of Thoracic Surgeons 1, 4

The European Society for Medical Oncology recommends that concurrent chemoradiotherapy is the treatment of choice for unresectable stage III disease 6, 7
The National Comprehensive Cancer Network suggests using platinum-based chemotherapy (cisplatin or carboplatin) with radiation 6, 7
Deliver 60-66 Gy in 30-33 daily fractions over a maximum of 7 weeks, as recommended by the American Society for Radiation Oncology 6, 7
Consolidation durvalumab (10 mg/kg every 2 weeks for up to 12 months) starting 1-42 days after chemoradiotherapy has demonstrated survival benefit, according to the European Society for Medical Oncology 6, 7

The British Journal of Cancer advises never proceeding with surgery or chemoradiation while active infection persists, as this dramatically increases morbidity and mortality 1
The American College of Radiology recommends avoiding pneumonectomy if possible in patients with recent infectious complications 1, 2
The American Thoracic Society suggests ensuring adequate pulmonary reserve assessment before any surgical consideration, as both abscess and potential resection compromise lung function 1, 4